1. Home
  2. ARDX vs PCN Comparison

ARDX vs PCN Comparison

Compare ARDX & PCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$3.83

Market Cap

996.8M

Sector

Health Care

ML Signal

HOLD

Logo Pimco Corporate & Income Strategy Fund

PCN

Pimco Corporate & Income Strategy Fund

HOLD

Current Price

$11.78

Market Cap

872.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
PCN
Founded
2007
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
996.8M
872.0M
IPO Year
2014
2001

Fundamental Metrics

Financial Performance
Metric
ARDX
PCN
Price
$3.83
$11.78
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$15.14
N/A
AVG Volume (30 Days)
4.8M
341.7K
Earning Date
04-30-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,607,000.00
N/A
Revenue This Year
$37.75
N/A
Revenue Next Year
$34.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.73
$11.40
52 Week High
$8.40
$13.49

Technical Indicators

Market Signals
Indicator
ARDX
PCN
Relative Strength Index (RSI) 27.50 53.23
Support Level N/A $11.56
Resistance Level $6.47 $11.83
Average True Range (ATR) 0.14 0.09
MACD 0.01 0.00
Stochastic Oscillator 12.33 49.40

Price Performance

Historical Comparison
ARDX
PCN

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About PCN Pimco Corporate & Income Strategy Fund

PIMCO Corporate & Income Strategy Fund is a closed-end management investment company. Its objective is to seek high current income with capital appreciation as a secondary objective. It invests in corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, short-term instruments, and others.

Share on Social Networks: